Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 4.29M | 0.48 | $ 8.95M |
3/31/2025 | $ 13.95M | 1.34 | $ 10.45M |
12/31/2024 | $ 23.82M | 1.48 | $ 16.05M |
9/30/2024 | $ 34.14M | 3.23 | $ 10.56M |
6/30/2024 | $ 50.72M | 3.25 | $ 15.62M |
3/31/2024 | $ 60.95M | 4.64 | $ 13.14M |
12/31/2023 | $ 80.47M | 5.06 | $ 15.91M |
9/30/2023 | $ 97.56M | 7.53 | $ 12.95M |
6/30/2023 | $ 122.2M | 6.8 | $ 17.97M |
3/31/2023 | $ 144.5M | 6.73 | $ 21.48M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for CARISMA THERAPEUTICS INC is calculated as follows: AssetsC [ $ 49.04M ] / LiabilitesC [ $ 9.71M ]
(=) Current Ratio [ 5.05 ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |